About OPTM Healthcare – Non-Surgical Pain Management Since 2011
Dr. Apurba Ganguly founded OPTM to treat chronic pain from blood biomarkers and plant-based compounds — not from a default referral to the operating theatre.
Dr. Apurba Ganguly
Ph.D. Biochemistry, M.Sc, M.D, Ph.D. (Pain & Phytomedicine)
He asked whether joint pain starts in the joint. Usually, it doesn't.
In the 1980s, Dr. Apurba Ganguly — a PhD biochemist — started asking why some people with “mild” X-rays could barely walk, while others with ugly scans had little pain. His working theory: chronic joint pain is often a muscle and metabolic problem first. 35+ years, 10,000+ patients, and a European Medical Association award later, that is still how we work.
His research pointed to hidden muscle degeneration — he called it MD-OADs — that standard MRIs and X-rays miss. So we measure 60+ blood biomarkers, estimate muscle biological age, and treat the biology imaging never shows. Plant-molecular therapy is the treatment layer. The bloodwork is the map.
We opened in 2011 because surgery and painkillers were the only two answers most people got
Since 2011 we have asked a simpler question: can we treat the biology driving the pain, without a joint replacement, a steroid series, or a lifetime of tablets?
Our Mission
Give people in India a third option besides “live with it” and “replace the joint.” We run AI on 60+ blood biomarkers, then treat the biology we find. That is the whole mission.
Our Vision
Chronic pain should not be a life sentence. Walk in, get a written explanation of the cause, a plan measured in weeks, and a way forward that does not start with a scalpel.
Four rules we actually follow in clinic
10,000+ patients later, these still decide how we diagnose and how we treat.
Measure first
97% diagnostic accuracy on our AI bloodwork, built on 35+ years of biochemistry research.
Your markers, your plan
Treatment follows your biomarker profile, not a photocopied physio sheet.
Published, then practised
We do not run a protocol we have not put in a journal or a clinic audit.
Outside recognition
Awards from the European Medical Association, AYUSH, and pain-medicine bodies. The clinic numbers still matter more.
Published Medical Journals & Research
Dr. Apurba Ganguly's 35+ years of clinical research is documented across 120+ peer-reviewed publications in international medical journals — indexed on NIH/PubMed, ResearchGate, IABCR, and more. Every claim OPTM makes is backed by verifiable science.
NIH / PubMed Central (2025)
Molecular Signatures of Varicosity: Diagnostic Insights from Ten Biomarker Panels
Dr. Ganguly's landmark 2025 NIH-indexed research demonstrating how a ten-panel biomarker approach provides superior diagnostic accuracy for vascular and musculoskeletal conditions — the same methodology powering OPTM's Bio-Musculo Index.
IABCR — Systematic Meta-Analysis (2024)
Efficacy of Phytotherapeutic Protocol for Risk Factor Reduction in Musculoskeletal Degeneration
A peer-reviewed systematic meta-analysis confirming that OPTM's phytotherapeutic protocol significantly reduces musculoskeletal degeneration risk factors — published in the International Archives of BioMedical and Clinical Research.
IOMC Proceedings — Clinical Research
Pain Diagnostic Protocol and Topical Phytotherapeutic Treatment for Osteoarthritic Disorders and Prevention
Clinical evidence demonstrating how OPTM's proprietary pain diagnostic protocol combined with topical phytotherapy provides measurable relief and prevention outcomes for osteoarthritic disorders.
Journal of Drug Delivery & Therapeutics (JDDT)
Phytotherapeutic Formulation for Musculoskeletal Conditions
Peer-reviewed research on the drug delivery mechanisms of OPTM's nano-concentrated plant compounds, demonstrating targeted delivery and efficacy for chronic musculoskeletal pain.
International Journal of Pharmacognosy (IJP)
Phytomedicine Clinical Application Study
Pharmacognosy research published in IJP validating the botanical ingredients and formulation science behind OPTM's phytotherapy protocol for musculoskeletal disorders.
European Journal of Pharmaceutical & Medical Research (EJPMR)
Phytomedicine Clinical Study — European Peer Review
European peer-reviewed validation of Dr. Ganguly's phytomedicine findings, providing international scientific credibility to OPTM's treatment protocols.
Journal of Orthopaedics Research (Avens Publishing)
Phytomolecular Treatment for Orthopaedic Joint Disorders
Orthopaedics-focused peer-reviewed study directly supporting OPTM's non-surgical joint treatment outcomes, published in Avens Publishing's Journal of Orthopaedics Research.
Longdom Publishing SL — Journal Series
Clinical & Cellular Immunology, Healthy Aging & Cell Science Journal Publications
Multiple peer-reviewed papers across Longdom's journal network covering nano-phyto compound immunological effects, cytokine pathway modulation, and healthy aging applications.
Rheumatology Conference Series — International Speaker (2016)
Nano-Phyto Pharmacy Approach to Musculoskeletal Conditions
Dr. Ganguly's invited speaker session at an international Rheumatology conference presenting the nano-phyto pharmacy research that laid the groundwork for OPTM's current treatment platform.
View Dr. Ganguly's Full Publication Portfolio
120+ peer-reviewed publications indexed across international research databases
Find out what your bloodwork says about the pain
You get a 60+ biomarker assessment, a sit-down with a pain clinician, and a written report in plain English: what we found, what we can treat, and how many weeks that usually takes. No pressure to start the same day.
Assessment includes AI diagnosis, a specialist consult, and a written report